Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay

Journal of Neuroscience Methods

Volumn 102, Issue 1, 2000, Pages 61-68

  Clarke, Earl E ^a   Shearman, Mark S ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid precursor protein

Indexed keywords

AMYLOID BETA PROTEIN;

ACCURACY; ADULT; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID; CULTURE MEDIUM; DIAGNOSTIC VALUE; EXTRACT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; NONHUMAN; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; BLOOD CHEMICAL ANALYSIS; CELLS, CULTURED; CULTURE MEDIA; FLUOROIMMUNOASSAY; HUMAN; MALE; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; TIME FACTORS;

EID: 0034668139     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(00)00280-6     Document Type: Article

References (32)

1. Borchelt D.R., Thinakaran G., Eckman C.B. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
2. Citron M., Oltersdorf T., Haass C. et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 360:1992;672-674.
3. Citron M., Diehl T.S., Gordon G., Biere A.L., Seubert P., Selkoe D.J. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA. 93:1996;13170-13175.
4. Citron M., Westaway D., Xia W. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
5. Cook D.G., Forman M.S., Sung J.C. et al. Alzheimer's Abeta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3:1997;1021-1023.
6. Duff K., Eckman C., Zehr C. et al. Increased amyloidβ-42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
7. Goate A., Chartier-Harlin M.-C., Mullan M. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
8. Gravina S.A., Ho L., Eckman C.B. et al. Amyloid β protein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270:1995;7013-7016.
9. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12:1991;383-388.
10. Hardy J., Duff K., Hardy K., Perez-Tur J., Hutton M. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nat. Neurosci. 1:1998;355-358.
11. Hartmann T., Bieger S.C., Brühl B. et al. Distinct sites of intracellular production for Alzheimer's disease Abeta40/42 amyloid peptides. Nat. Med. 3:1997;1016-1020.
12. Holcomb L., Gordon M.N., McGowan E. et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:1998;97-100.
13. Ida N., Hartmann T., Pantel J. et al. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J. Biol. Chem. 271:1996;22908-22914.
14. Iwatsubo T., Mann D.M., Okada A., Suzuki N., Ihara Y. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann. Neurol. 37:1995;294-299.
15. Johnson-Wood K., Lee M., Motter R. et al. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;1550-1555.
16. Khorkova O.E., Patel K., Heroux J., Sahasrabudhe S. Modulation of amyloid precursor protein processing by compounds with various mechanisms of action: detection by liquid phase electrochemiluminescent system. J. Neurosci. Methods. 82:1998;159-166.
17. Kim K.S., Miller D.L., Sapienza V.J. et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2:1988;121-130.
18. Kim K.S., Wen G.Y., Bancher C., Chen C.-M.J., Sapienza V.J., Hong H., Wisniewski H.M. Detection and quantitation of amyloid b-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7:1990;113-122.
19. Kolb AJ, Harrison P, Mathis G. Time-resolved fluorescent assay technology. Laboratory News 1997, January issue.
20. Kolb A.J., Kaplita P.V., Hayes D.J., Park Y.-W., Pernell C., Major J.S., Mathis G. Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence. Drug Discov. Today. 3:1998;333-342.
21. Lemere C.A., Lopera F., Kosik K.S. et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2:1996;1146-1150.
22. Levy-Lahad E., Wasco W., Poorkaj P. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
23. Motter R., Vigo-Pelfrey C., Kholodenko D. et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38:1995;643-648.
24. Sabbagh M.N., Galasko D., Thal L.J. β-Amyloid and treatment opportunities for Alzheimer's disease. Alzheimer's Dis. Rev. 3:1997;1-19.
25. Scheuner D., Eckman C., Jensen M. et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
26. Selkoe D.J. Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
27. Sherrington R., Rogaev E.I., Liang Y. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
28. Suzuki N., Cheung T.T., Cai X.D. et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
29. Thinakaran G., Teplow D.B., Siman R., Greenberg B., Sisodia S.S. Metabolism of the 'Swedish' amyloid precursor protein variant in Neuro2a (N2a) cells. J. Biol. Chem. 271:1996;9390-9397.
30. Tienari P.J., Ida N., Ikonen E. et al. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA. 94:1997;4125-4130.
31. Tokuda T., Fukushima T., Ikeda S., Sekijima Y., Shoji S., Yanagisawa N., Tamaoka A. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome. Ann. Neurol. 41:1997;271-273.
32. Xia W., Zhang J., Kholodenko D. et al. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272:1997;7977-7982.